EyePoint, Inc. (EYPT)
4.875
-0.44
(-8.36%)
USD |
NASDAQ |
Aug 24, 16:00
4.89
+0.02
(+0.31%)
After-Hours: 20:00
EyePoint Shareholders Equity (Quarterly) : 166.41M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 166.41M |
| March 31, 2026 | 230.47M |
| December 31, 2025 | 306.11M |
| September 30, 2025 | 200.18M |
| June 30, 2025 | 246.01M |
| March 31, 2025 | 298.40M |
| December 31, 2024 | 336.50M |
| September 30, 2024 | 218.73M |
| June 30, 2024 | 228.30M |
| March 31, 2024 | 249.93M |
| December 31, 2023 | 266.32M |
| September 30, 2023 | 58.62M |
| June 30, 2023 | 57.26M |
| March 31, 2023 | 78.39M |
| December 31, 2022 | 96.37M |
| September 30, 2022 | 136.35M |
| June 30, 2022 | 151.37M |
| March 31, 2022 | 166.82M |
| December 31, 2021 | 184.38M |
| September 30, 2021 | 92.75M |
| June 30, 2021 | 106.86M |
| March 31, 2021 | 115.71M |
| December 31, 2020 | 18.54M |
| September 30, 2020 | 7.594M |
| June 30, 2020 | 4.188M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.47M |
| December 31, 2019 | 8.33M |
| September 30, 2019 | 15.94M |
| June 30, 2019 | 28.21M |
| March 31, 2019 | 19.88M |
| December 31, 2018 | 37.63M |
| September 30, 2018 | 47.70M |
| June 30, 2018 | 11.69M |
| March 31, 2018 | 8.198M |
| June 30, 2017 | 13.34M |
| March 31, 2017 | 12.51M |
| December 31, 2016 | 14.76M |
| September 30, 2016 | 14.45M |
| June 30, 2016 | 20.88M |
| March 31, 2016 | 26.55M |
| December 31, 2015 | 14.42M |
| September 30, 2015 | 18.82M |
| June 30, 2015 | 23.37M |
| March 31, 2015 | 27.85M |
| December 31, 2014 | 32.28M |
| September 30, 2014 | 35.80M |
| June 30, 2014 | 14.92M |
| March 31, 2014 | 18.35M |
| December 31, 2013 | 12.60M |
| September 30, 2013 | 14.24M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 520.04M |
| Eli Lilly & Co. | 33.88B |
| Elanco Animal Health, Inc. | 6.588B |
| Amylyx Pharmaceuticals, Inc. | 239.17M |
| Nuvation Bio, Inc. | 253.86M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 228.19M |
| Total Liabilities (Quarterly) | 61.78M |
| Debt to Equity Ratio | 0.1344 |
| Current Ratio | 4.502 |
| Net Debt Paydown Yield | 0.03% |